AGIO vs ZBIO: stock comparison and AI forecast
Agios Pharmaceuticals, Inc. (AGIO) and Zenas Biopharma, Inc. (ZBIO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AGIO Agios Pharmaceuticals, Inc.
- Price
- $30.55 +9.1% · 6M
- Market Cap
- $1.82B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
ZBIO Zenas Biopharma, Inc.
- Price
- $27.62 +28.1% · 6M
- Market Cap
- $1.80B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AGIO and ZBIO have similar market capitalizations ($1.82B and $1.80B).
- Over the last six months ZBIO returned +28.1% and AGIO +9.1%.
- AGIO turns -530.1% of its revenue into net income, against -48438.4% for ZBIO.
- ZBIO carries 1.84 times debt per unit of equity, against 0.08 times for AGIO.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AGIO | ZBIO |
|---|---|---|
| Market Cap | $1.82B | $1.80B |
| P/B Ratio | 1.78x | 7.29x |
| EPS | $-7.02 | $-10.42 |
| Book Value/Share | $17.19 | $3.79 |
| Revenue/Share | $1.30 | – |
| FCF/Share | $-6.12 | $-3.47 |
Profitability & Margins
| Metric | AGIO | ZBIO |
|---|---|---|
| ROE | -40.1% | -196.0% |
| ROA | -37.1% | -69.0% |
| ROIC | -44.2% | -74.8% |
| Gross Margin | 91.5% | – |
| Operating Margin | -591.6% | -47557.3% |
| Net Margin | -530.1% | -48438.4% |
| EBT Margin | -516.4% | -48416.4% |
| Tax Rate | 0.6% | -0.1% |
Financial Health
| Metric | AGIO | ZBIO |
|---|---|---|
| Current Ratio | 10.22x | 9.93x |
| Quick Ratio | 9.71x | – |
| D/E Ratio | 0.08x | 1.84x |
| Financial Leverage | 1.08x | 2.84x |
| Interest Coverage | – | -79.6x |
| Working Capital | $647M | $588M |
Cash Flow
| Metric | AGIO | ZBIO |
|---|---|---|
| Operating Cash Flow | -$361M | -$226M |
| Free Cash Flow | -$365M | -$226M |
| Capital Spending | -$5M | $0.00M |
| FCF/Sales | -470.7% | – |
| CapEx/Sales | 6.0% | – |
Operational Efficiency
| Metric | AGIO | ZBIO |
|---|---|---|
| Asset Turnover | 0.07x | – |
| Inventory Turnover | 0.2x | – |
| Fixed Assets Turnover | 7.8x | – |
| Days Inventory | 1658 days | – |
| Payables Period | 758 days | – |
Income Statement
| Metric | AGIO | ZBIO |
|---|---|---|
| Total Revenue | $78M | – |
| Operating Income | -$459M | -$476M |
| Net Income | -$411M | -$484M |
| R&D Expense | $357M | $213M |
| SG&A Expense | $193M | – |
| Cost of Goods Sold | $8M | – |
Dividend & Shareholder Information
| Metric | AGIO | ZBIO |
|---|---|---|
| Shares Outstanding | 60M | 65M |
| Net Income Growth | -163.3% | – |
| EPS Growth | -162.1% | – |
AGIO vs ZBIO: stock comparison and AI forecast
Which is bigger, AGIO or ZBIO?
AGIO and ZBIO have similar market capitalizations ($1.82B and $1.80B).
Which stock performed better over the last six months, AGIO or ZBIO?
Over the last six months ZBIO returned +28.1% and AGIO +9.1%.
Which one does Intratio's AI model rank higher, AGIO or ZBIO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.